Stock screenerAll disclosures →
EDGAR →
MYGN
Conviction 8HealthcareScan · Mon, Aug 10, 2026MYGN$3.26+0.00%
ResistanceSupportVol 14Insider buyInsider sellVol MA14 3.26M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price3.26
Change+0.00%
Gap-1.07%
Rel volume1.39×
Avg volume2.53M
Avg $ vol9.4M
SMA 204.83
SMA 504.95
SMA 2005.45
Price vs 50-34.11%
Price vs 200-40.19%
MA stackbearish
50/200 cross—
Supertrenddown · 4.39
RSI (14)29
MACD hist-0.24
MACD cross—
Stoch %K / %D17 / 15
ADX (14)41
+DI / −DI12 / 41
RSI divergence—
MACD divergence—
ATR %+11.40%
ADR %6.07%
52w high8.18
52w low2.86
From 52w high-60.15%
Above 52w low+13.99%
New 52w highNo
SqueezeOff
Bollinger width106.51%
%B0.19
Donchian pos14.09%
Donchian high6.43
Donchian low2.74
AVWAP (52w high)5.05
vs AVWAP high-35.45%
AVWAP (52w low)3.10
vs AVWAP low+5.02%
OBV trendFlat
Chaikin MF (20)-0.12
Today vs 20d1.39×
Avg vol (14d)3.26M
Avg vol (20d)2.53M
Avg $ vol (20d)9.4M
Market cap—
RS 3m (vs SPY)-25.99%
RS 6m (vs SPY)-50.19%
RS line new highNo
Trend template0/8
Technical rank9.3
1 week+7.95%
1 month-44.08%
3 months-24.01%
6 months-36.33%
1 year-46.56%
YTD-46.91%
P/E-0.85
P/B1.02
P/S0.38
P/FCF-7.16
EPS-3.95
Div yield—
ROE-120.40%
ROA-57.27%
Debt/Eq0.59
Current2.21
EV/EBITDA-0.99
Gross margin69.93%
Net margin-44.38%
Rev growth-1.56%
EPS growth-187.43%
Price target4.68
Target upside43.78%
Analyst ratingHold
Institutional102.84%
Ent. value376.24M
Revenue190.7M
Net income-43.2M
Gross profit127M
Free cash flow-43.5M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out94.45M
Employees2.7K
ListedFri, Oct 6, 1995
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank9.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance6.34
Support3.57
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MYGN
No recent disclosed trades by Congress in MYGN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MYGN · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kumar Rashmi Director · Common Stock · 2026-06-08 | Sell | 15K | $67K | 2026-06-08 | 2026-06-09 |
Dreismann Heinrich Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Bisaro Paul Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Newcomer Lee Nisley Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Davis Mark Steven Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Phanstiel S. Louise Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Kumar Rashmi Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Reitan Colleen F Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Skovronsky Daniel Director · Common Stock · 2026-06-04 | Grant | 59.7K | $0 | 2026-06-04 | 2026-06-05 |
Jampa Raj Chief Technology Officer · Common Stock · 2026-06-01 | Grant | 251.89K | $0 | 2026-06-01 | 2026-06-02 |
SEC filings
EDGAR filings in MYGN · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.